WeedMD to Convert Toronto-Based CannDo to its First Cannabis Education Centre

Internationally-Renowned Cannabis Advocate & Pioneer Amy “Anonymous” Brown to Oversee Education Centre as it launches “Pop-Up Shop” on October 16-18

Toronto, Canada, October 16, 2018 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has signed an agreement for a pilot project to convert a popular Toronto-based medical cannabis centre to a WeedMD cannabis education centre (“Education Centre”). Internationally-renowned medical cannabis advocate Amy Brown, also known as Amy Anonymous, will oversee the Education Centre with a preview “Pop-up Shop” opening on October 16-18, located at 685 Yonge Street, 2nd Floor in Toronto, Ontario.

“As one of the cannabis industry’s pioneers and a staunch and knowledgeable advocate, Amy has been helping patients navigate safe cannabis use for over a decade and it’s an honour to welcome Amy, her patients and her peer group to the WeedMD family,” said Keith Merker, CEO of WeedMD. “With the onset of legalization, our industry has a long way to go in helping the general public understand cannabis strains, terpene profiles, dosing, safety, etc. and Amy’s team is an added asset to our WeedMD Education Centre pilot project. This further exemplifies our commitment to our medical patients which is strongly rooted in everything we do.“

“When I started down the path of cannabis advocacy over 10 years ago, there was a limited number of trusted and knowledgeable influencers in the space but my long-standing relationship with the crusaders that planted the first seeds at WeedMD comes full-circle today as we partner to advance the need for cannabis education,” said Amy Brown, General Manager of WeedMD’s Education Centre. “Today I’m proud to officially join the team and I know that my loyal patients will transition seamlessly to the WeedMD family who’s commitment to the medical cannabis patient will always be at the core of its value system. Its promise to provide us with consistent medical-grade supply, free shipping and the absorbing of the excise tax are further validations to our partnership and commitment.”

About the “Education Centre Pop-up Shop”

Patient educators and clinical service providers will be on hand to counsel current and prospective medical patients on strain selection, consumption methods, dosing, cannabis oil derivatives and optimal home grow options provided by WeedMD. Visit the Education Centre Pop-up Shop starting October 16 from the hours of 12am to 6pm. The WeedMD Education Centre is located at 685 Yonge Street, 2nd floor, Toronto, Ontario, M4Y 2B2. [link here for map].

For more information, access WeedMD’s investor presentation here and recently updated corporate video here.

About WeedMD Inc.

WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of cannabis and cannabis oil under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates two facilities: a 26,000 sq. ft. indoor facility in Aylmer, Ontario and a state-of-the-art greenhouse facility located in Strathroy, Ontario. The Greenhouse currently has 44,000 square feet of licensed space in production and is expected to have a total footprint of more than 500,000 square feet online by year-end 2018. WeedMD has a multi-channeled distribution strategy that includes supply agreements with Shoppers Drug Mart and provincial distribution agencies, as well as through strategic relationships across the seniors’ market in Canada.

Follow WeedMD On:

   

For further information, please contact:

WeedMD Inc.

Keith Merker, Chief Executive Officer
Tel: 519-765-2440 Ext. 222
Email: investor@weedmd.com

To learn more, visit us at www.weedmd.com

For Media Enquiries:

Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com

Cautionary Statement on Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s Annual Information Form dated December 13, 2017 (the “AIF”) and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

 


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE



WELCOME

Are you the age of majority in your province?
(19+, or 18+ in Alberta and Quebec)

   

By entering our site you are agreeing to our
Terms of Use and Privacy Policy.